Elequin Capital’s NorthView Acquisition Corporation Rights NVACR Stock Holding History

Elequin Capital’s Portfolio NVACR Stock Details NVACR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-25,000	Closed	-$2.18K	–	513
2023 Q4	$2.18K	Hold	25,000	–	–	﹤0.01%	288
2023 Q3	$4.25K	Hold	25,000	–	–	﹤0.01%	292
2023 Q2	$3.5K	Hold	25,000	–	–	﹤0.01%	408
2023 Q1	$4.25K	Hold	25,000	–	–	﹤0.01%	228
2022 Q4	$4.31K	Buy	+25,000	New	+$2.9K	﹤0.01%	540

Other funds holding NVACR

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

ASM

ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Elequin Capital's NVACR Position: Q1 2024 in Review

Elequin Capital sold out of NorthView Acquisition Corporation Rights (NVACR) in Q1 2024, closing a stake of 25,000 shares — an estimated $2.18K sold.

Elequin Capital first reported a position in NVACR in Q4 2022 and held it in 5 quarters. The position peaked at $4.31K in Q4 2022. 33 funds tracked by Wall St. Rank hold NVACR as of Q1 2024.

Elequin Capital reported no remaining NorthView Acquisition Corporation Rights position as of Q1 2024 after selling out during the quarter.
Elequin Capital sold 25,000 NorthView Acquisition Corporation Rights shares in Q1 2024, an estimated $2.18K.
Elequin Capital first reported a position in NorthView Acquisition Corporation Rights in Q4 2022 and held it in 5 quarters.
Elequin Capital's NorthView Acquisition Corporation Rights position peaked at $4.31K in Q4 2022.
33 funds tracked by Wall St. Rank held NorthView Acquisition Corporation Rights as of Q1 2024.

Based on Elequin Capital's 13F filing for Q1 2024, filed 15 May 2024.